Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Benchtop Analyzer Designed for Routine Clinical Chemistry Testing

By LabMedica International staff writers
Posted on 03 Aug 2011
A fully automated, compact, random access chemistry analyzer for use in small laboratory settings is an easy to use, cost-effective system

Dubbed Indiko, the analyzer is designed for routine clinical chemistry testing and specialty testing such as specific proteins, drug of abuse testing, and therapeutic drug monitoring including immunosuppressant drug monitoring (ISD).

A mix of barcoded primary tubes and sample cups can be used at any time, increasing the flexibility of operation. More...
Patient oriented testing produces results quickly thus enhancing the quality of patient care.

Features of Indiko include advanced dilution management and real-time monitoring of reagent usage, which help to manage a daily workload. Samples, reagents, and consumables can continuously be loaded without interrupting the testing process, and different sample types can be analyzed at the same time. A real-time QC program with multiple Westgard Rules assures the reliable performance. Application data as well as calibrator and control values are loadable from a file or from a two-dimensional barcode by the barcode scanner.

The test flow definition allows for up to four reagent additions in each test, offering automation even for the most complex methods. The cuvette design supports low reagent volumes thus reducing operating costs, especially important when working with specialty tests.

Thermo Fisher Scientific (Waltham, MA, USA) introduced Indiko during the American Association for Clinical Chemistry (AACC) 2011 conference, which was held from July 26-28, 2011, at the Georgia World Congress Center, Atlanta (GA, USA). The analyzer has received US Food and Drug Administration (FDA; Silver Spring, MD, USA) clearance.

Additional information about the Indiko analyzer may be found online (please see Related Links below).


Related Links:
Thermo Fisher Scientific
Thermo Scientific Indiko
US Food and Drug Administration



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Capillary Blood Collection Tube
IMPROMINI M3
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.